96 related articles for article (PubMed ID: 29295643)
21. Comprehensive cytogenetic and molecular cytogenetic analysis of 44 Burkitt lymphoma cell lines: secondary chromosomal changes characterization, karyotypic evolution, and comparison with primary samples.
Maria Murga Penas E; Schilling G; Behrmann P; Klokow M; Vettorazzi E; Bokemeyer C; Dierlamm J
Genes Chromosomes Cancer; 2014 Jun; 53(6):497-515. PubMed ID: 24590883
[TBL] [Abstract][Full Text] [Related]
22. Interphase fluorescence in situ hybridization for detection of 8q24/MYC breakpoints on routine histologic sections: validation in Burkitt lymphomas from three geographic regions.
Haralambieva E; Schuuring E; Rosati S; van Noesel C; Jansen P; Appel I; Guikema J; Wabinga H; Bleggi-Torres LF; Lam K; van den Berg E; Mellink C; van Zelderen-Bhola S; Kluin P
Genes Chromosomes Cancer; 2004 May; 40(1):10-8. PubMed ID: 15034863
[TBL] [Abstract][Full Text] [Related]
23. Low incidence of MYC/BCL2 double-hit in Burkitt lymphoma.
Yoshida M; Ichikawa A; Miyoshi H; Kiyasu J; Kimura Y; Niino D; Ohshima K
Pathol Int; 2015 Sep; 65(9):486-9. PubMed ID: 26182827
[TBL] [Abstract][Full Text] [Related]
24. [Clinicopathologic and immunohistochemical study of intra-abdominal non-Hodgkin B-cell lymphoma occurring in children].
Yang WP; Zhu CD; Gong LP; Lü BB; Zou Y; Zhong HS; Xiao Q; Wu Y; Xu HY; Zeng ST; Huang H
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):759-64. PubMed ID: 20079016
[TBL] [Abstract][Full Text] [Related]
25. Apoptosis resistance, mitotic catastrophe, and loss of ploidy control in Burkitt lymphoma.
Chumduri C; Gillissen B; Richter A; Richter A; Milojkovic A; Overkamp T; Müller A; Pott C; Daniel PT
J Mol Med (Berl); 2015 May; 93(5):559-72. PubMed ID: 25548804
[TBL] [Abstract][Full Text] [Related]
26. Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report.
Lee S; Day NS; Miles RR; Perkins SL; Lim MS; Ayello J; van de Ven C; Harrison L; El-Mallawany NK; Goldman S; Cairo MS
Br J Haematol; 2017 May; 177(4):601-611. PubMed ID: 28474336
[TBL] [Abstract][Full Text] [Related]
27. Genetic sequencing studies in Burkitt's lymphoma: what can we learn about tumorigenesis?
Soldini D; Campo E
Expert Rev Hematol; 2013 Jun; 6(3):219-21. PubMed ID: 23782073
[No Abstract] [Full Text] [Related]
28. Successful salvage chemotherapy for isolated central nervous system (CNS) relapse in Burkitt lymphoma: monocentric experience of 3 pediatric patients.
Baleydier F; Pondarre C; Pages MP; Mialou V; Kebaili K; Pracros JP; Bertrand Y
J Pediatr Hematol Oncol; 2008 Dec; 30(12):972-5. PubMed ID: 19131795
[TBL] [Abstract][Full Text] [Related]
29. Combined spectral karyotyping, comparative genomic hybridization, and in vitro apoptyping of a panel of Burkitt's lymphoma-derived B cell lines reveals an unexpected complexity of chromosomal aberrations and a recurrence of specific abnormalities in chemoresistant cell lines.
Karpova MB; Schoumans J; Blennow E; Ernberg I; Henter JI; Smirnov AF; Nordenskjöld M; Fadeel B
Int J Oncol; 2006 Mar; 28(3):605-17. PubMed ID: 16465364
[TBL] [Abstract][Full Text] [Related]
30. Plasma Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi.
Westmoreland KD; Montgomery ND; Stanley CC; El-Mallawany NK; Wasswa P; van der Gronde T; Mtete I; Butia M; Itimu S; Chasela M; Mtunda M; Kampani C; Liomba NG; Tomoka T; Dhungel BM; Sanders MK; Krysiak R; Kazembe P; Dittmer DP; Fedoriw Y; Gopal S
Int J Cancer; 2017 Jun; 140(11):2509-2516. PubMed ID: 28268254
[TBL] [Abstract][Full Text] [Related]
31. p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53.
Lindström MS; Klangby U; Wiman KG
Oncogene; 2001 Apr; 20(17):2171-7. PubMed ID: 11360201
[TBL] [Abstract][Full Text] [Related]
32. A case of clonally distinct relapse of Burkitt lymphoma 9 years after complete remission.
Kojima M; Nakamura N; Yabe M; Tokunaka M; Kikuti YY; Kikuchi T; Murayama H; Moriuchi M; Tsuboi K; Ogawa Y; Ando K
Int J Hematol; 2015 May; 101(5):520-4. PubMed ID: 25555480
[TBL] [Abstract][Full Text] [Related]
33. Histone deacetylase inhibitor prevents cell growth in Burkitt's lymphoma by regulating PI3K/Akt pathways and leads to upregulation of miR-143, miR-145, and miR-101.
Ferreira AC; Robaina MC; Rezende LM; Severino P; Klumb CE
Ann Hematol; 2014 Jun; 93(6):983-93. PubMed ID: 24577510
[TBL] [Abstract][Full Text] [Related]
34. Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens.
Carey CD; Gusenleitner D; Chapuy B; Kovach AE; Kluk MJ; Sun HH; Crossland RE; Bacon CM; Rand V; Dal Cin P; Le LP; Neuberg D; Sohani AR; Shipp MA; Monti S; Rodig SJ
J Mol Diagn; 2015 Jan; 17(1):19-30. PubMed ID: 25468432
[TBL] [Abstract][Full Text] [Related]
35. Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons.
Hutchison RE; Finch C; Kepner J; Fuller C; Bowman P; Link M; Schwenn M; Laver J; Desai S; Barrett D; Murphy SB
Ann Oncol; 2000; 11 Suppl 1():35-8. PubMed ID: 10707776
[TBL] [Abstract][Full Text] [Related]
36. Pediatric B-Cell Lymphoma With Lymphoblastic Morphology, TdT Expression, MYC Rearrangement, and Features Overlapping With Burkitt Lymphoma.
Meznarich J; Miles R; Paxton CN; Afify Z
Pediatr Blood Cancer; 2016 May; 63(5):938-40. PubMed ID: 26785246
[TBL] [Abstract][Full Text] [Related]
37. Burkitt lymphoma (BL): reclassification of 39 lymphomas diagnosed as BL or Burkitt-like lymphoma in the past based on immunohistochemistry and fluorescence in situ hybridization.
Kodet R; Mrhalová M; Stejskalová E; Kabícková E
Cesk Patol; 2011 Jul; 47(3):106-14. PubMed ID: 21887927
[TBL] [Abstract][Full Text] [Related]
38. New clues to the molecular pathogenesis of Burkitt lymphoma revealed through next-generation sequencing.
Greenough A; Dave SS
Curr Opin Hematol; 2014 Jul; 21(4):326-32. PubMed ID: 24867287
[TBL] [Abstract][Full Text] [Related]
39. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression.
Leucci E; Onnis A; Cocco M; De Falco G; Imperatore F; Giuseppina A; Costanzo V; Cerino G; Mannucci S; Cantisani R; Nyagol J; Mwanda W; Iriso R; Owang M; Schurfeld K; Bellan C; Lazzi S; Leoncini L
Int J Cancer; 2010 Mar; 126(6):1316-26. PubMed ID: 19530237
[TBL] [Abstract][Full Text] [Related]
40. Burkitt's lymphoma is a malignancy of mature B cells expressing somatically mutated V region genes.
Klein U; Klein G; Ehlin-Henriksson B; Rajewsky K; Küppers R
Mol Med; 1995 Jul; 1(5):495-505. PubMed ID: 8529116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
